1Didier S, Cyrille F, Henri B. Hepatitis viruses and liver transplantation[J]. J Gastro Hepat, 1997;12(suppl):335-41
2Trepo C,Jezek P,Atkinson GF,et al.Efficacy of famiclovir in chronic hepatitis B:results of a dose finding study[J]. Hepatology, 1996;24:188-92
3Ling R,Mutimer D,Ahmed M,et al. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine[J]. Hepatology,1996;24:711-3
4Herrero JI,Quiroga J,Sangro B,et al. Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation[J]. Dig Dis Sci, 1998;43:1186-9
5Gish RG,Imperial JI, Esquivel CO,et al.Ganciclovir treatment of hepatitis B virus infection[J]. Gastroenterology, 1993;104:116-23
6Ghany MG,Ayola B, Villamil FG,et al. Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis[J]. Hepatology, 1998;27:213-22
7Samuel D, Bismuth A, Mathieu D, et al. Liver transplantation in European patients with the hepatitis B surface antigen[J]. N Engl J Med, 1993;329:1842-7
8Liaw YF. Current therapeutic trends in therapy for chronic viral hepatitis[J]. J Gastro Hepat, 1997;(12suppl):346-53
9Grellier L, Mutimer D, Ahmed M,et al. Lamivudine prophylaxis against reinfection in lver transplantation for hepatitis B cirrhosis[J]. Lancet, 1996;348:1212
